Somewhat Positive Press Coverage Somewhat Unlikely to Affect Cyanotech (CYAN) Stock Price
News articles about Cyanotech (NASDAQ:CYAN) have been trending somewhat positive recently, according to Accern. Accern identifies negative and positive news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cyanotech earned a media sentiment score of 0.07 on Accern’s scale. Accern also assigned news coverage about the biotechnology company an impact score of 46.8328327328648 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
Separately, ValuEngine cut shares of Cyanotech from a “hold” rating to a “sell” rating in a research report on Friday, November 10th.
Cyanotech (NASDAQ CYAN) traded up $0.11 during trading on Thursday, hitting $4.01. 1,000 shares of the stock traded hands, compared to its average volume of 1,350. The stock has a market cap of $22.40, a PE ratio of 66.83 and a beta of 1.06. Cyanotech has a 1-year low of $3.25 and a 1-year high of $5.35. The company has a current ratio of 2.36, a quick ratio of 0.72 and a debt-to-equity ratio of 0.33.
Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company’s products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids.
Receive News & Ratings for Cyanotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech and related companies with MarketBeat.com's FREE daily email newsletter.